Belite Bio (BLTE) EBITDA

Annual EBITDA

-$31.20 M
-$18.77 M-150.92%

December 31, 2023


Summary


Performance

BLTE EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLTEprofitabilitymetrics:

Quarterly EBITDA

-$9.74 M
+$731.00 K+6.98%

September 1, 2024


Summary


Performance

BLTE Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLTEprofitabilitymetrics:

TTM EBITDA

-$35.42 M
+$1.22 M+3.33%

September 1, 2024


Summary


Performance

BLTE TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLTEprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

BLTE EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-150.9%-41.5%-12.1%
3 y3 years-446.0%-41.5%-12.1%
5 y5 years-446.0%-41.5%-12.1%

BLTE EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-223.8%at low-825.0%+11.1%-3264.1%+3.3%
5 y5-year-446.0%at low-825.0%+11.1%-3264.1%+3.3%
alltimeall time-446.0%at low-825.0%+11.1%-3264.1%+3.3%

Belite Bio EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$9.74 M(-7.0%)
-$35.42 M(-3.3%)
Jun 2024
-
-$10.47 M(+25.7%)
-$36.65 M(+10.9%)
Mar 2024
-
-$8.33 M(+21.0%)
-$33.05 M(+4.6%)
Dec 2023
-$31.20 M
-$6.88 M(-37.2%)
-$31.60 M(+1.1%)
Sep 2023
-
-$10.96 M(+59.5%)
-$31.25 M(+36.9%)
Jun 2023
-
-$6.87 M(-0.1%)
-$22.82 M(+23.6%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$6.88 M(+5.3%)
-$18.46 M(+46.1%)
Dec 2022
-$12.43 M(+29.0%)
-$6.53 M(+157.2%)
-$12.63 M(+107.1%)
Sep 2022
-
-$2.54 M(+1.4%)
-$6.10 M(+71.4%)
Jun 2022
-
-$2.51 M(+138.0%)
-$3.56 M(+238.0%)
Mar 2022
-
-$1.05 M
-$1.05 M
Dec 2021
-$9.64 M(+68.6%)
-
-
Dec 2020
-$5.71 M
-
-

FAQ

  • What is Belite Bio annual EBITDA?
  • What is the all time high annual EBITDA for Belite Bio?
  • What is Belite Bio annual EBITDA year-on-year change?
  • What is Belite Bio quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Belite Bio?
  • What is Belite Bio quarterly EBITDA year-on-year change?
  • What is Belite Bio TTM EBITDA?
  • What is the all time high TTM EBITDA for Belite Bio?
  • What is Belite Bio TTM EBITDA year-on-year change?

What is Belite Bio annual EBITDA?

The current annual EBITDA of BLTE is -$31.20 M

What is the all time high annual EBITDA for Belite Bio?

Belite Bio all-time high annual EBITDA is -$5.71 M

What is Belite Bio annual EBITDA year-on-year change?

Over the past year, BLTE annual EBITDA has changed by -$18.77 M (-150.92%)

What is Belite Bio quarterly EBITDA?

The current quarterly EBITDA of BLTE is -$9.74 M

What is the all time high quarterly EBITDA for Belite Bio?

Belite Bio all-time high quarterly EBITDA is -$1.05 M

What is Belite Bio quarterly EBITDA year-on-year change?

Over the past year, BLTE quarterly EBITDA has changed by -$2.85 M (-41.47%)

What is Belite Bio TTM EBITDA?

The current TTM EBITDA of BLTE is -$35.42 M

What is the all time high TTM EBITDA for Belite Bio?

Belite Bio all-time high TTM EBITDA is -$1.05 M

What is Belite Bio TTM EBITDA year-on-year change?

Over the past year, BLTE TTM EBITDA has changed by -$3.83 M (-12.11%)